Aspartame and Cancer Risk
Does aspartame cause cancer?
Short answer: no regulator has found that aspartame causes cancer at the levels people actually consume. IARC lists it as "possibly carcinogenic to humans" (Group 2B). That rating describes how strong the evidence of a possible hazard is, not how likely you are to get cancer. The bodies that assess dietary risk (JECFA, EFSA and the FDA) have each concluded it is safe within its acceptable daily intake (ADI).
Approach: I searched the IARC Monographs classification list, EFSA's published opinions, the consolidated EU food additives Regulation (EC) No 1333/2008, the FDA's Substances Added to Food inventory and California's Proposition 65 list. I also read the 2023 WHO/IARC/JECFA outputs and the FDA's aspartame page on their official sites.
Hazard classification (IARC)
- IARC lists aspartame (CAS 22839-47-0) in Group 2B. It was evaluated in 2023 and published in Volume 134 [1].
- The basis was "limited" evidence in humans for one cancer type, hepatocellular carcinoma (a liver cancer). This came from only three studies that used artificially sweetened drinks as a stand-in for aspartame intake. Chance, bias or confounding could not be ruled out (JECFA/IARC summary of findings).
- The animal evidence was also rated "limited" because of problems with how the studies were designed and how tumours were diagnosed. The mechanistic evidence was "limited" too, mainly signs of oxidative stress in experimental systems.
- IARC states that its groups "do not indicate the degree of risk of developing cancer at a given exposure level" (same source).
Dietary risk assessments
- JECFA (July 2023): found "no convincing evidence from experimental animal or human data that aspartame has adverse effects after ingestion" and kept the ADI at 0–40 mg/kg body weight. Aspartame breaks down completely in the gut into phenylalanine, aspartic acid and methanol, and none of it enters the bloodstream intact. Some cohort studies reported increases in liver, breast and blood cancers, but JECFA found no consistent link to any one cancer type (JECFA/IARC summary). WHO gives an example: a 70 kg adult would need to drink more than 9–14 cans a day of a diet soft drink with 200–300 mg aspartame per can to exceed the ADI (WHO, 14 July 2023).
- EFSA (2013 full re-evaluation of E 951): the Panel "concluded that there was no convincing evidence for genotoxic or carcinogenic potential of aspartame in experimental animals". It agreed with the NOAEL of 4000 mg/kg bw/day and found no risk from the methanol aspartame releases at the 40 mg/kg bw/day ADI [2].
- The positive animal studies: the studies reporting tumours were run by the Ramazzini Foundation (ERF). EFSA had reviewed them in 2006 and 2009. In the first rat study it judged the lymphomas/leukaemias to be incidental and the kidney tumours irrelevant to humans [3]. In 2013 it found the rat studies had "major deficiencies", including chronic lung inflammation in the test animals [4]. It found the mouse liver and lung tumours fell within the lab's own historical control ranges [5].
- FDA: its scientists "do not have safety concerns when aspartame is used under the approved conditions of use". The FDA's ADI is 50 mg/kg bw/day. The agency says it "disagrees with IARC's conclusion" and points to "significant shortcomings in the studies on which IARC relied" (FDA).
Where it stands in law
- EU: E 951 aspartame is still authorised in Annex II of Regulation 1333/2008. The current consolidated text lists 35 food categories, for example category 18.2 at 800 [6].
- US: the FDA inventory lists aspartame as a non-nutritive sweetener and flavour enhancer under 21 CFR 172.804 [7].
- California: I found no aspartame entry in the Proposition 65 chemicals list.
Questions about aspartame's other possible effects remain open. WHO and IARC have called for better cohort studies and trials, and JECFA did not find recent associations with type 2 diabetes and cerebrovascular disease convincing.
Is it still allowed in the EU and US?
Yes, aspartame is still a permitted sweetener in both the EU and the US. In the EU it is authorised as E 951 in the current consolidated Regulation (EC) No 1333/2008, as consolidated on 18 August 2026. In the US it is approved as a food additive under 21 CFR 172.804. Both regimes require a phenylalanine warning on the label.
Approach: I checked the current consolidated text of Regulation 1333/2008 (the Annex II Union list and Article 23 labelling rules), 21 CFR Part 172 in the eCFR, and the FDA's Substances Added to Food inventory.
EU (Regulation 1333/2008, Annex II, E 951)
- E 951 aspartame has 47 Annex II entries covering 35 food categories in the consolidated text dated 18 August 2026. The categories run from 01.4 (flavoured fermented milk products) to 18.2 (meal replacements for weight control).
- Each entry has its own maximum level, and some carry restrictions. Examples:
- Under Article 23(3)(b), table-top sweeteners containing aspartame or aspartame-acesulfame salt must carry the warning "contains a source of phenylalanine" [11].
US (21 CFR 172.804)
- Aspartame "may be safely used in food in accordance with good manufacturing practice as a sweetening agent and a flavor enhancer" in foods whose standards of identity do not preclude it. It must meet the Food Chemicals Codex specifications [12].
- Conditions of use in the same section:
- In baked goods and baking mixes, it may not exceed 0.5% by weight of the ready-to-bake product or the formulation before baking.
- In sugar-substitute tablets, L-leucine may be used as a lubricant at up to 3.5% of tablet weight.
- Every food containing aspartame must carry the statement "PHENYLKETONURICS: CONTAINS PHENYLALANINE".
- Table-use sweeteners must be labelled not to be used in cooking or baking [12].
- The FDA inventory lists aspartame (CAS 22839-47-0) as a non-nutritive sweetener and flavour enhancer, with 172.804 as its regulation [7].
The current EU and US texts show no ban or withdrawal of aspartame after IARC classified it in 2023.
If it helps, I can list all 35 EU food categories with their maximum levels and restrictions.
What about stevia and sucralose?
Yes, both are still permitted in the EU and the US. In the current consolidated Regulation (EC) No 1333/2008, sucralose (E 955) has 49 Annex II entries across 35 food categories, and steviol glycosides (now the E 960a-960d group) have 43 entries across 33 categories. In the US, the legal route differs between the two. Sucralose is an approved food additive under 21 CFR 172.831. Purified steviol glycosides are not approved additives; they are on the market through GRAS notices the FDA did not question, and the FDA does not allow whole-leaf or crude stevia as a sweetener.
Approach: I checked the consolidated Regulation 1333/2008 (dated 18 August 2026) and its amending acts, 21 CFR Parts 170-189, the FDA's Substances Added to Food inventory and GRAS Notice Inventory, IARC's classification list and EFSA's opinions. I also read the FDA's sweeteners page.
Sucralose (E 955)
- EU: E 955 is authorised in categories from 01.4 (flavoured fermented milk products) to 18.2 (meal replacements), with category-specific limits. Examples:
- EFSA re-evaluation (2026):
- The ADI stays at 15 mg/kg bw per day, and no exposure estimate exceeded it. The Panel found "no safety concern at the reported uses and use levels" and no safety concerns for genotoxicity [16].
- On cancer, it found sucralose exposure "is not associated with cancer (moderate level of confidence)" in the human studies [17].
- Open points: EFSA could not conclude on a proposed extension to energy-reduced fine bakery wares (category 7.2, 700 mg/kg). This was because chlorinated compounds might form during baking. The Panel also recommended tighter EU specifications: individual limits for 4-CG and 1,6-DCF, a lower lead limit, and adding the CAS number [18]. I found no 2026 amending act on sucralose in the datasets.
- US:
- Under 21 CFR 172.831, sucralose "may be used as a sweetener in foods generally" under good manufacturing practice, at no more than the amount reasonably required [19].
- The FDA inventory lists it at CAS 56038-13-2 under that section [20].
- The FDA says it approved sucralose for 15 food categories in 1998 and as a general-purpose sweetener in 1999. It reviewed more than 110 studies, including on carcinogenicity, and sets an ADI of 5 mg/kg bw/day (FDA).
Stevia (steviol glycosides, E 960a-960d)
- EU:
- E-number split: Regulation (EU) 2021/1156 renamed E 960 as E 960a "Steviol glycosides from Stevia" and added E 960c "Enzymatically produced steviol glycosides" [21].
- 2025 addition: Regulation (EU) 2025/652 added E 960b "Steviol glycosides from fermentation". The group is now E 960a-960d, including E 960d glucosylated steviol glycosides [22]. The group's maximum levels apply combined and are expressed as steviol equivalents [23].
- ADI: the existing ADI is 4 mg/kg bw per day [24].
- Examples of current limits:
- US:
- I found no 21 CFR food additive regulation for steviol glycosides.
- GRAS route: the GRAS Notice Inventory holds 86 steviol glycoside notices. The FDA had no questions on 84, ceased evaluating 1 at the notifier's request (GRN 867), and has 1 pending (GRN 1318). Examples range from GRN 252 (rebaudioside A, 2008) [28] to GRN 1310 (rebaudioside M, closed 6 July 2026) [29].
- Whole leaf and crude extracts: the FDA states that "the use of stevia leaf and crude stevia extracts is not considered GRAS, and their import into the U.S. is not permitted for use as sweeteners" (FDA).
Cancer classification: I found no IARC entry for sucralose or for stevia or steviol glycosides. Unlike aspartame, neither has an IARC group in the classification list.
I can write out the full category-by-category EU limits for both sweeteners, or list all 86 US GRAS notices, if that would help.